Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) EPS (Basic): 2012-2024

Historic EPS (Basic) for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to -$1.22.

  • Ocular Therapeutix's EPS (Basic) fell 72.73% to -$0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.43, marking a year-over-year decrease of 8.33%. This contributed to the annual value of -$1.22 for FY2024, which is 20.79% down from last year.
  • As of FY2024, Ocular Therapeutix's EPS (Basic) stood at -$1.22, which was down 20.79% from -$1.01 recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's EPS (Basic) registered a high of -$0.09 during FY2021, and its lowest value of -$2.56 during FY2020.
  • Its 3-year average for EPS (Basic) is -$1.05, with a median of -$1.01 in 2023.
  • In the last 5 years, Ocular Therapeutix's EPS (Basic) soared by 96.48% in 2021 and then crashed by 922.22% in 2022.
  • Ocular Therapeutix's EPS (Basic) (Yearly) stood at -$2.56 in 2020, then soared by 96.48% to -$0.09 in 2021, then plummeted by 922.22% to -$0.92 in 2022, then declined by 9.78% to -$1.01 in 2023, then declined by 20.79% to -$1.22 in 2024.